Cargando…
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration
OBJECTIVE: Yo antibodies are associated with paraneoplastic cerebellar degeneration (PCD). We have characterized Yo sera by measuring CDR2 and CDR2L antibodies and the localization of their antigens. METHODS: Forty-two Yo sera from patients with paraneoplastic neurological syndromes (PNS), 179 sera...
Autores principales: | Eichler, Tilo W., Totland, Cecilie, Haugen, Mette, Qvale, Tor H., Mazengia, Kibret, Storstein, Anette, Haukanes, Bjørn I., Vedeler, Christian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688866/ https://www.ncbi.nlm.nih.gov/pubmed/23823982 http://dx.doi.org/10.1371/journal.pone.0066002 |
Ejemplares similares
-
Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker
por: Herdlevær, Ida, et al.
Publicado: (2021) -
Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer
por: Totland, Cecilie, et al.
Publicado: (2018) -
CDR2 antigen and Yo antibodies
por: Totland, Cecilie, et al.
Publicado: (2010) -
Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration
por: Herdlevær, Ida, et al.
Publicado: (2020) -
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
por: Schubert, Manja, et al.
Publicado: (2014)